Asthmatics With Increased Triglyceride-Glucose Index Are at Elevated Risk of Exacerbations Independent of Type 2 Inflammation: A Prospective Cohort study
The Journal of Allergy and Clinical Immunology: In Practice · 2026-11 · 14 (11) · 2634-2647.e7
DOI: 10.1016/j.jaip.2026.08.012 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026-11. Verfasst von Ke Deng und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chen…. Hauptthemen laut MEDLINE: Asthma, Triglycerides, Inflammation, Blood Glucose. Die Arbeit nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan University West China Hospital, Sichuan Province Science and Technology Support Program.
Abstract (Originalsprache)
BACKGROUND: The triglyceride-glucose (TyG) index is a new alternative marker for insulin resistance and metabolic dysfunction, which has recently been linked to lung health. However, the link among the TyG index, type 2 (T2) inflammation, and asthma is largely unexplored. OBJECTIVES: To explore clinical, inflammatory characteristics and exacerbations in patients with asthma grouped by the TyG index with or without T2 inflammation. METHODS: This was a prospective cohort study with 12-month follow-up based on the Australasian Severe Asthma Network. Patients with stable asthma were divided into the TyGlow and TyGhigh groups by the 75th percentile values of the TyG index. Subgroups were analyzed based on T2 status. All participants with stable asthma (n = 626) underwent multidimensional assessment and sputum induction. Univariate and multivariable negative binomial regression analyses were used to examine the relationship between asthma exacerbations and TyG index with or without T2 inflammation. RESULTS: Patients with asthma in the TyGhigh group (n = 156) had higher body mass index, worse metabolic function and airway obstruction, more comorbidities including diabetes and metabolic syndrome, and increased risk of exacerbations independent of T2 inflammation, compared with the TyGlow group (n = 470). Furthermore, the TyGhigh T2low group was at significantly increased risk of moderate-to-severe exacerbations (adjusted incidence rate ratio [IRR] = 2.54, 95% confidence interval [CI] = [1.56, 4.15], P < .001), emergency visits (adjusted IRR = 7.88, 95% CI = [2.71, 22.92], P < .001), and unscheduled visits (adjusted IRR = 2.87, 95% CI = [1.65, 4.98], P < .001). CONCLUSIONS: The TyG index is a promising biomarker of asthma exacerbations, highlighting the clinical relevance of assessing the TyG index in asthma management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, China; State Key Laboratory of Respiratory Health and Mu…
- State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-…
- Department of Respiratory and Critical Care Medicine, Tongji Hospital, Huazhong University of Science & Technology, Wuhan, Hubei, China.
- Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital of Jilin University, Changchun, Jilin, China.
- Signature Research Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
- Department of Respiratory and Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Förderung
- National Natural Science Foundation of China
- Sichuan University West China Hospital
- Sichuan Province Science and Technology Support Program
- Sichuan Province Department of Science and Technology
- China International Medical Foundation
- Chengdu Science and Technology Bureau
Zitieren
APA
Deng, K., Wang, J., Gao, S. Y., Zhang, X., Xie, M., Zhang, J., Chen-Yu Hsu, A., Qin, L., Oliver, B. G., Liu, D., Wood, L. G., Chen, Z. H., Wark, P. A. B., Luo, F. M., Li, W. M., & Wang, G. (2026). Asthmatics With Increased Triglyceride-Glucose Index Are at Elevated Risk of Exacerbations Independent of Type 2 Inflammation: A Prospective Cohort study. The Journal of Allergy and Clinical Immunology: In Practice, 14(11), 2634-2647.e7. https://doi.org/10.1016/j.jaip.2026.08.012
Vancouver
Deng K, Wang J, Gao SY, Zhang X, Xie M, Zhang J, et al. Asthmatics With Increased Triglyceride-Glucose Index Are at Elevated Risk of Exacerbations Independent of Type 2 Inflammation: A Prospective Cohort study. The Journal of Allergy and Clinical Immunology: In Practice. 2026;14(11):2634-2647.e7. doi:10.1016/j.jaip.2026.08.012
BibTeX
@article{Deng2026,
author = {Deng, Ke and Wang, Ji and Gao, Si Yang and Zhang, Xin and Xie, Min and Zhang, Jie and Chen-Yu Hsu, Alan and Qin, Ling and Oliver, Brian G and Liu, Dan and Wood, Lisa G and Chen, Zhi Hong and Wark, Peter A B and Luo, Feng Ming and Li, Wei Min and Wang, Gang},
title = {Asthmatics With Increased Triglyceride-Glucose Index Are at Elevated Risk of Exacerbations Independent of Type 2 Inflammation: A Prospective Cohort study},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2026},
volume = {14},
number = {11},
pages = {2634--2647.e7},
doi = {10.1016/j.jaip.2026.08.012}
}
EUVIMED